Finasteride and dutasteride are the two most-prescribed oral medications for androgenetic alopecia (pattern hair loss) in men. Both belong to the same drug class — 5-alpha-reductase inhibitors — and both work by lowering dihydrotestosterone (DHT), the hormone primarily responsible for shrinking genetically susceptible hair follicles. The difference comes down to how completely they block DHT, how long they stay in your system, and their regulatory status.
How they work: blocking DHT at the source
Testosterone is converted into DHT by an enzyme called 5-alpha-reductase, which exists in multiple forms (isoenzymes). Finasteride inhibits the type II isoenzyme — the form dominant in hair follicles and the prostate. Dutasteride inhibits both type I and type II. The practical result: finasteride at 1 mg daily lowers serum DHT by roughly 70%, while dutasteride at 0.5 mg daily lowers it by more than 90%.
What head-to-head studies show
A randomized controlled trial published in the Journal of the American Academy of Dermatology compared dutasteride 0.5 mg to finasteride 1 mg in men with androgenetic alopecia and found dutasteride produced greater increases in hair count and thickness at 24 weeks. Subsequent meta-analyses have generally supported the finding that dutasteride is the more potent of the two for hair regrowth, which is consistent with its more complete DHT suppression.
FDA approval status matters
Finasteride 1 mg is FDA-approved specifically for male androgenetic alopecia. Dutasteride is FDA-approved for benign prostatic hyperplasia (enlarged prostate) but not for hair loss in the United States — its use for hair loss is off-label, though it holds regulatory approval for hair loss in South Korea and Japan. Off-label prescribing is legal and common, but it means the prescribing decision rests on clinical judgment, which is why a proper evaluation by a licensed clinician matters.
Half-life and what it means for side effects
Finasteride has a serum half-life of roughly 6–8 hours; dutasteride's is around 4–5 weeks. That long half-life means dutasteride's effects — therapeutic and adverse — persist far longer after stopping. Reported side effects for both drugs include decreased libido, erectile dysfunction, and reduced ejaculate volume in a small percentage of men. Anyone considering either drug should have a candid discussion of risks and benefits with their prescriber, and women who are or may become pregnant must not handle crushed or broken tablets of either medication due to risk to a male fetus.
Topical and compounded options
For patients who want DHT suppression concentrated at the scalp with lower systemic exposure, compounded topical finasteride — often combined with minoxidil in a single serum — has become an increasingly studied option. Research suggests topical finasteride can lower scalp DHT with substantially smaller effects on serum DHT than the oral route.
Which one is right for you?
There's no universal answer. A clinician weighs your degree and pattern of loss, your age, how you've responded to prior treatment, your tolerance for off-label prescribing, and your side-effect risk profile. Some patients start with finasteride and escalate to dutasteride only if response is inadequate after 12 months; others with aggressive loss may be candidates for dutasteride earlier. The right answer comes from an individualized medical evaluation — not a one-size-fits-all subscription.
This content is for informational purposes only. Consult a licensed provider before starting any treatment.